LTP — Ltr Pharma Balance Sheet
0.000.00%
- AU$80.89m
- AU$61.23m
- AU$1.62m
Annual balance sheet for Ltr Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.91 | 1.73 | 3.1 | 31.8 | 19.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0.265 | 0.247 | 0.247 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.95 | 1.79 | 3.37 | 32.1 | 20.7 |
| Net Property, Plant And Equipment | — | — | 0.002 | 0.013 | 0.013 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 2.25 | 2.09 | 3.37 | 32.2 | 20.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.476 | 0.021 | 0.429 | 0.701 | 0.601 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.476 | 0.021 | 0.429 | 0.701 | 0.601 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.77 | 2.07 | 2.94 | 31.5 | 20.3 |
| Total Liabilities & Shareholders' Equity | 2.25 | 2.09 | 3.37 | 32.2 | 20.9 |
| Total Common Shares Outstanding |